Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients-Reference-Cited by-同舟云学术

Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients

Published:2009-11-13 Issue:4 Volume:51 Page:1137-1143
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Feuerstadt Paul,Bunim Ari L.,Garcia Heriberto,Karlitz Jordan J.,Massoumi Hatef,Thosani Amar J.,Pellecchia Andrew,Wolkoff Allan W.,Gaglio Paul J.,Reinus John F.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23429/fullpdf

Reference23 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

3. Peginterferon-alpha 2a and ribavirin combintion therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

4. A comparison of observational studies and randomized, controlled trials;Benson;N Eng J Med,2003

5. Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice;Lee;Aliment Pharmacol Ther,2006

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals;Digestive Diseases and Sciences;2024-07-11

2. Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment;Time & Society;2022-09-22

3. Barriers to accessing sterile injecting equipment for people who inject drugs: An integrative review;Journal of Clinical Nursing;2022-09-06

4. Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan;Medicina;2022-04-07

5. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma;Journal of Vascular and Interventional Radiology;2020-06